Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients.

Fortuin FD, Vale P, Losordo DW, Symes J, DeLaria GA, Tyner JJ, Schaer GL, March R, Snell RJ, Henry TD, Van Camp J, Lopez JJ, Richenbacher W, Isner JM, Schatz RA.

Am J Cardiol. 2003 Aug 15;92(4):436-9.

PMID:
12914874
2.

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).

Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila E, Simula S, Närvänen O, Rantala A, Peuhkurinen K, Nieminen MS, Laakso M, Ylä-Herttuala S.

Circulation. 2003 Jun 3;107(21):2677-83. Epub 2003 May 12.

4.

Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road.

Patterson C, Runge MS.

Circulation. 2000 Aug 29;102(9):940-2. No abstract available.

5.

Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia--do the effects really add up?

Heilmann CA, Attmann T, von Samson P, Göbel H, Marmé D, Beyersdorf F, Lutter G.

Eur J Cardiothorac Surg. 2003 Jan;23(1):74-80.

PMID:
12493508
6.

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH.

Circulation. 2003 Oct 21;108(16):1933-8. Epub 2003 Sep 22.

7.

Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.

Rajagopalan S, Mohler E 3rd, Lederman RJ, Saucedo J, Mendelsohn FO, Olin J, Blebea J, Goldman C, Trachtenberg JD, Pressler M, Rasmussen H, Annex BH, Hirsch AT; Regional Angiogenesis With Vascular Endothelial Growth Factor trial..

Am Heart J. 2003 Jun;145(6):1114-8.

PMID:
12796772
8.

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.

Khan TA, Sellke FW, Laham RJ.

Gene Ther. 2003 Feb;10(4):285-91. Review.

PMID:
12595887
9.

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG.

Circulation. 1999 Aug 3;100(5):468-74.

10.

Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review.

Kusumanto YH, Hospers GA, Mulder NH, Tio RA.

Int J Cardiovasc Intervent. 2003;5(1):27-34. Review.

PMID:
12623562
11.

Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia.

Shyu KG, Chang H, Wang BW, Kuan P.

Am J Med. 2003 Feb 1;114(2):85-92.

PMID:
12586226
12.

Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector.

Magovern CJ, Mack CA, Zhang J, Hahn RT, Ko W, Isom OW, Crystal RG, Rosengart TK.

Ann Thorac Surg. 1996 Aug;62(2):425-33; discussion 433-4.

PMID:
8694601
13.

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?

Lewis BS, Flugelman MY, Weisz A, Keren-Tal I, Schaper W.

Cardiovasc Res. 1997 Sep;35(3):490-7. Review.

PMID:
9415293
14.

Intramuscular vascular endothelial growth factor gene therapy: fact or fiction?

Baumgartner I.

Am J Med. 2003 Feb 1;114(2):156-7. No abstract available.

PMID:
12586239
15.

Catheter-based myocardial gene transfer for therapeutic angiogenesis in patient with chronic myocardial ischemia.

Surawicz B.

Cardiol Rev. 2002 Jan-Feb;10(1):2-3. No abstract available.

PMID:
11858142
16.

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER; VIVA Investigators..

Circulation. 2003 Mar 18;107(10):1359-65.

17.

Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor.

Baumgartner I, Rauh G, Pieczek A, Wuensch D, Magner M, Kearney M, Schainfeld R, Isner JM.

Ann Intern Med. 2000 Jun 6;132(11):880-4.

PMID:
10836914
18.

[Therapeutic angiogenesis by angiogenic growth factor].

Makino H, Ogihara T, Morishita R.

Nihon Rinsho. 2003 Apr;61 Suppl 4:692-7. Review. Japanese. No abstract available.

PMID:
12735051
19.

Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits.

Tanaka E, Hattan N, Ando K, Ueno H, Sugio Y, Mohammed MU, Voltchikhina SA, Mori H.

J Thorac Cardiovasc Surg. 2000 Oct;120(4):720-8.

20.

Gene therapy for ischemic heart disease: therapeutic potential.

Symes JF.

Am J Cardiovasc Drugs. 2001;1(3):159-66. Review.

PMID:
14728030

Supplemental Content

Support Center